With the competition struggling, Pfizer’s COVID vaccine sales could hit $24B this year: analyst kdunleavy Mon, 04/19/2021 – 15:01 More: With the competition struggling, Pfizer's COVID vaccine sales could hit B this year: analyst Source: fierce
read moreAs variants take hold, FDA revokes authorization of Eli Lilly’s solo COVID-19 antibody nhigginsdunn Mon, 04/19/2021 – 11:19 More: As variants take hold, FDA revokes authorization of Eli Lilly's solo COVID-19 antibody Source: fierce
read moreJohnson & Johnson’s COVID shot could return by late this week with some extra safety warnings: Fauci fkansteiner Mon, 04/19/2021 – 11:03 More: Johnson & Johnson's COVID shot could return by late this week with some extra safety warnings: Fauci
read moreFDA orders shutdown at Emergent’s troubled plant 2 weeks after handing J&J the keys kdunleavy Mon, 04/19/2021 – 10:10 More: FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys Source: fierce
read moreSeagen, Astellas eye fast FDA review for Padcev’s expanded bladder cancer use, with all-important Keytruda combo data to come aliu Mon, 04/19/2021 – 09:47 More: Seagen, Astellas eye fast FDA review for Padcev's expanded bladder cancer use, with all-important Keytruda
read moreFive-year strategy will seek to transform key elements of organisation’s approach to latest treatments More: NICE unveils new strategy to improve patient access to innovative treatments Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals